Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. Supreme Court revives bar on abortion pill mail delivery in pandemic

Stock MarketsJan 12, 2021 07:00PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

By Andrew Chung

(Reuters) - The U.S. Supreme Court on Tuesday reinstated a requirement that women visit a hospital or clinic to obtain a drug used for medication-induced abortions, lifting an order by a lower court allowing the drug to be mailed or delivered as a safety measure during the coronavirus pandemic.

The justices granted a request by President Donald Trump's administration to lift a federal judge's July order that had suspended the U.S. Food and Drug Administration's (FDA) rule requiring in-person visits for the duration of the pandemic.

The pandemic is still raging nationwide. Coronavirus infections remain at record highs in many U.S. states. Nearly 130,000 Americans were hospitalized with COVID-19 as of midnight on Monday and the country had reported 22.5 million infections and 376,188 deaths.

The court's three liberal justices said they would have denied the Trump administration's request while litigation over the dispute continues in lower courts.

U.S. District Judge Theodore Chuang in Greenbelt, Maryland in July found that due to the health risks that COVID-19 poses, the in-person requirements "place a substantial obstacle in the path of women seeking a medication abortion" and likely violate their constitutional rights.

Chuang's injunction said the government had taken actions to effectively waive several in-person requirements for dispensing other drugs, including opioids.

Justice Sonia Sotomayor took issue with that disparity in a dissent on Tuesday. "This country's laws have long singled out abortions for more onerous treatment than other medical procedures," she wrote, adding that the FDA's rule imposes an "unjustifiable, irrational, and undue burden on women seeking an abortion during the current pandemic."

In a brief opinion concurring in the decision, Chief Justice John Roberts said the dispute was not generally about the right to abortion but rather courts' deference to government decisions related to the pandemic.

The dispute centers on the FDA's requirement that the drug mifepristone, one of two pills used to perform a medication abortion, be dispensed in-person by a certified prescriber. Medication abortions are approved through the first 10 weeks of pregnancy.

Groups representing tens of thousands of physicians, including the American College of Obstetricians and Gynecologists, sued the FDA in May saying that requiring in-person visits to pick up a pill needlessly exposes patients, doctors, and workers to a greater risk of contracting COVID-19.

The groups said this is especially true given that evaluations and counseling may be done through telemedicine and that the drug itself may be taken elsewhere.

U.S. Supreme Court revives bar on abortion pill mail delivery in pandemic
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email